Asset-Backed Promissory Note, High ROI, Whiskey Conversion Option at Maturity
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$2,291,371
Across 6 rounds since 2016
Latest share price
$9.10
Reg CF Offering (2026) offering price
Financials
FY2014–FY2025 (no data for FY2021) · from SEC filings · hover any figure for its source
$1.5M
−$380K
2017
$1.7M
−$328K
2018
$2.0M
−$167K
2019
$2.2M
$60K
2020
2021no data
$3.5M
$212K
2022
$2.6M
−$1.5M
2023
$1.6M
−$2.2M
2024
$1.4M
−$1.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Chart shows the most recent 8 fiscal years; 3 earlier years are in the table below.
Metric
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$964,192
$1,075,304
$949,511
$1,527,833
$1,687,182
$2,005,312
$2,242,509
$3,477,860
$2,570,934
$1,590,575
$1,369,503
Cost of goods sold
$589,419
$477,495
$523,691
$653,956
$710,834
$901,198
$877,607
$1,364,278
$1,779,571
$851,551
$660,776
Gross margin
39%
56%
45%
57%
58%
55%
61%
61%
31%
46%
52%
Net income
-$577,998
-$85,411
-$526,237
-$380,407
-$327,615
-$167,102
$60,458
$211,844
-$1,499,836
-$2,194,084
-$1,131,041
Taxes paid
$0
$0
$0
$0
$0
$0
$20,000
$0
$0
$0
$0
Balance sheet
Cash
$100,811
$200,802
$565,621
$77,872
$568,248
$347,889
$468,953
$385,219
$208,131
$192,945
$250,516
Accounts receivable
$97,723
$67,538
$66,432
$139,184
$193,706
$232,956
$260,183
$425,897
$294,641
$25,913
$118,964
Total assets
$965,104
$1,228,213
$1,440,342
$1,106,703
$1,689,137
$1,425,629
$1,789,610
$4,335,676
$8,115,509
$6,796,337
$6,863,398
Short-term debt
$778,223
$938,684
$172,425
$207,858
$529,474
$313,380
$231,295
$1,002,924
$3,012,254
$3,507,297
$1,155,193
Long-term debt
$344,994
$316,426
$665,712
$623,211
$683,729
$617,243
$648,047
$2,125,114
$4,874,011
$5,245,203
$8,486,243
Total liabilities
$1,123,217
$1,255,110
$838,137
$831,069
$1,213,203
$930,623
$879,342
$3,128,039
$7,886,265
$8,752,500
$9,641,436
Other
Headcount
—
7
—
15
14
14
16
—
8
8
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.
